BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 6373140)

  • 1. Allogeneic bone marrow transplantation.
    Weiden PL
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC; McGuire TR
    Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
    Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors associated with interstitial pneumonia following allogeneic bone marrow transplantation for acute leukemia in Japanese experience.
    Inoue T; Masaoka T; Shibata H
    Strahlenther Onkol; 1986 Jun; 162(6):368-73. PubMed ID: 3526600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation in Canada.
    Buskard NA
    Can Med Assoc J; 1980 Jul; 123(1):19-22. PubMed ID: 6998551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation in children: Tokai experience 1982 to 1984.
    Kato S; Hoshi N; Nagasaka M; Muranaka S; Yabe H; Kimura M
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):147-58. PubMed ID: 3010509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone marrow transplantation in leukemia and aplastic anemia].
    Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
    Schweiz Med Wochenschr; 1983 Apr; 113(17):622-9. PubMed ID: 6346483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation in severe aplastic anemia and acute or chronic leukemia.
    Schaefer UW; Mahmoud HK; Beelen DW; Hoffmann W; Becher R; Schmidt CG; Bamberg M; Quast U; Haralambie E; Linzenmeier G
    Strahlenther Onkol; 1986 Apr; 162(4):214-7. PubMed ID: 3518096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in bone marrow transplantation in acute leukemia and aplastic anemia].
    Speck B; Cornu P; Sartorius J; Nissen C; Gratwohl A; Burri HP; Jeannet M
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1883-5. PubMed ID: 43594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications and results in bone marrow transplantation].
    Jeannet M; Chapuis B
    Ther Umsch; 1986 Feb; 43(2):138-43. PubMed ID: 3515608
    [No Abstract]   [Full Text] [Related]  

  • 13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic bone marrow transplantation for the patients with hemopoietic stem cell disorders: CUMC experience.
    Kim DJ; Kim CC; Park CW; Han CH; Kim HK; Kim WI; Han KJ; Choi IB
    Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1188-92. PubMed ID: 1514832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of marrow transplantation.
    Thomas ED
    West J Med; 1985 Dec; 143(6):834-7. PubMed ID: 3911595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-host disease after marrow transplantation.
    Storb R
    Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marrow transplantation: the Seattle experience.
    Storb R
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):75-83. PubMed ID: 3914747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantations at Huddinge Hospital and strategies to improve survival.
    Ringdén O; Aschan J; Boström L; Dahllöf G; Tollemar J; Paulin T; Gahrton G; Groth CG; Klaesson S; Lindquist R
    Clin Transpl; 1990; ():175-87. PubMed ID: 2103143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.